Huub J. Van Eyk
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Circulating FGF21 is lower in South Asians compared with Europids with type 2 diabetes mellitus.
Journal: Endocrine connections
Published: July 19, 2024
Growth differentiation factor 15 is not modified after weight loss induced by liraglutide in South Asians and Europids with type 2 diabetes mellitus.
Journal: Experimental physiology
Published: February 21, 2024
Ethnic Disparities in Lipid Metabolism and Clinical Outcomes between Dutch South Asians and Dutch White Caucasians with Type 2 Diabetes Mellitus.
Journal: Metabolites
Published: December 05, 2023
Altered high-density lipoprotein composition is associated with risk for complications in type 2 diabetes mellitus in South Asian descendants: A cross-sectional, case-control study on lipoprotein subclass profiling.
Journal: Diabetes, obesity & metabolism
Published: February 20, 2023
Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 14, 2022
Efficacy of liraglutide on glycemic endpoints in people of Western European and South Asian descent with T2DM using multiple daily insulin injections: results of the MAGNA VICTORIA studies.
Journal: Acta diabetologica
Published: October 10, 2020
Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double-Blind, Randomized, Placebo-Controlled Trial.
Journal: Journal of magnetic resonance imaging : JMRI
Published: September 12, 2019
Phenotyping diabetic cardiomyopathy in Europeans and South Asians.
Journal: Cardiovascular diabetology
Published: August 22, 2019
Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial.
Journal: Cardiovascular diabetology
Published: August 01, 2019
Liraglutide decreases energy expenditure and does not affect the fat fraction of supraclavicular brown adipose tissue in patients with type 2 diabetes.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: June 07, 2019
A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients.
Journal: Cardiovascular diabetology
Published: April 10, 2019
Last Updated: 09/26/2026